Titelia

Fund shareholders of HLS Therapeutics Inc

ISIN CA40390B1094 · Canada

Fund shareholders
7
Of which ETFs
1 6 other funds
Value held
63.9K $
FundSharesValueWeight in fund
The Canadian Small Company Series DFA INVESTMENT TRUST CO 4,50415.4K $0.00 %as of Apr 30, 2026
Dimensional International Small Cap ETF Dimensional ETF Trust 4,00013.7K $0.00 %as of Apr 30, 2026
Dimensional VA International Small Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 2,9039.9K $0.00 %as of Apr 30, 2026
SIIT SCREENED WORLD EQUITY EX-US FUND SEI INSTITUTIONAL INVESTMENTS TRUST 2,6008.6K $0.01 %as of Feb 28, 2026
LVIP Dimensional International Core Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST 2,3177.3K $0.00 %as of Mar 31, 2026
World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 2,0006.8K $0.00 %as of Apr 30, 2026
International Small Company Trust John Hancock Variable Insurance Trust 7002.2K $0.00 %as of Mar 31, 2026

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
SIIT SCREENED WORLD EQUITY EX-US FUND SEI INSTITUTIONAL INVESTMENTS TRUST 0.01 %as of Feb 28, 2026
Dimensional VA International Small Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026
International Small Company Trust John Hancock Variable Insurance Trust 0.00 %as of Mar 31, 2026
LVIP Dimensional International Core Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST 0.00 %as of Mar 31, 2026
The Canadian Small Company Series DFA INVESTMENT TRUST CO 0.00 %as of Apr 30, 2026
Dimensional International Small Cap ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026
World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q27-119,024-5.0 %
2026Q18+120,024+14.9 %
2025Q47-217,424-52.0 %
2025Q39036,3240.0 %
2025Q29-136,324-3.2 %
2025Q110+137,524+11.9 %
2024Q49-233,524-0.3 %
2024Q311033,6140.0 %
2024Q211033,6140.0 %
2024Q111033,6140.0 %
2023Q41133,614
Cite this page

Titelia. "Fund shareholders of HLS Therapeutics Inc". https://titelia.com/en/stocks/hls-therapeutics-inc-CA40390B1094